Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance
Abstract. Background:. B-cell activating factor (BAFF) is vital for B cell survival. Serum BAFF levels are elevated in thrombotic antiphospholipid syndrome, but little is known about levels in patients with positive antiphospholipid antibodies (aPLs) and previous adverse pregnancy outcomes (APOs). W...
Main Authors: | Xin-Yi Li, Hong-Ji Duan, Xiang-Yuan Liu, Xiao-Li Deng, Peng Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-10-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000000948 |
Similar Items
-
Antiphospholipid Antibodies and Antiphospholipid Syndrome During Pregnancy: Diagnostic Concepts
by: Roger A Levy, et al.
Published: (2015-05-01) -
Evaluation of Antiphospholipid Antibodies and Activated Partial Thromboplastin Time in Women with Adverse Outcome of Pregnancy
by: Sariyeh Golmahammad lou, et al.
Published: (2010-12-01) -
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
by: Cecilia Nalli, et al.
Published: (2021-06-01) -
Anaesthetic implications of antiphospholipid antibody syndrome in pregnancy
by: Priyanka Garg, et al.
Published: (2011-01-01) -
Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset
by: Nuwayhid Bahij S, et al.
Published: (2009-03-01)